Performance by category
Death-per-report rate within each category, compared to the corpus-wide average for that same category. Ratio > 1 means this manufacturer's mortality is higher than the field for that category; ratio < 1 means lower.
| Category | Devices | Reports | Deaths | Death rate | Corpus avg | vs corpus |
|---|---|---|---|---|---|---|
| Neurovascular | 477 | 39,597 | 143 | 0.36% | 2.52% | 0.14× |
| Cranial surgery | 36 | 1,398 | 1 | 0.07% | 0.38% | 0.19× |
| CSF / ICP | 9 | 394 | 1 | 0.25% | 0.89% | 0.29× |
| DBS / neuromodulation | 1 | 153 | 0 | 0.00% | 1.53% | 0.00× |
Temporal trajectory
Annual reports for this manufacturer's neurosurgical devices, split by FDA event type. Use it to spot inflection points (recall responses, product launches, reporting-pattern shifts).
Failure-mode signature
Per category, this manufacturer's failure-mode mix vs other manufacturers in the SAME category — an apples-to-apples comparison that strips out the confound of "which categories they happen to operate in." Click a category tab to drill in.
Highest-mortality devices
Top 10 of this manufacturer's devices ranked by death-per-report rate (minimum 100 reports to avoid small-sample noise). Click any device for its full profile.
| Device | Category | Reports | Deaths | Death rate |
|---|---|---|---|---|
| BD Cvc Kit: 3-LUMEN | Neurovascular | 119 | 5 | 4.20% |
| BD Mahurkar | Neurovascular | 368 | 7 | 1.90% |
| BD Powerglide Midline Catheter | Neurovascular | 158 | 3 | 1.90% |
| BD Cvc Set: 3-LUMEN | Neurovascular | 123 | 2 | 1.63% |
| BD Interlink Catheter Extension Set | Neurovascular | 128 | 2 | 1.56% |
| BD Unknown | Neurovascular | 3,917 | 61 | 1.56% |
| BD Nexiva Diffusics | Neurovascular | 332 | 3 | 0.90% |
| BD First Picc | Neurovascular | 812 | 7 | 0.86% |
| BD US Cathena Straight BC | Neurovascular | 126 | 1 | 0.79% |
| BD Interlink Injection Site | Neurovascular | 144 | 1 | 0.69% |